DalCor www.dalcorpharma.com
1 known investors
DalCor Pharmaceuticals develops dalcetrapib, a precision medicine treatment for cardiovascular disease targeting patients with a specific genetic marker (ADCY9 AA genotype). The company is conducting clinical trials to demonstrate the drug's ability to reduce heart attacks in post-acute coronary syndrome patients.
BiotechDigital HealthMedical Devices